Le Lézard
Classified in: Health, Business
Subjects: PER, SBS

World Congress Appoints New CEO, Benny DiCecca


WOBURN, Mass., Feb. 5, 2020 /PRNewswire/ -- World Congress Research (World Congress), a premier conference company known for its content and thought-leadership in the Health Care, Life Sciences, Human Resources, and Legal industries, recently announced the appointment of Benny DiCecca as Chief Executive Officer. With more than 30 years of business and sales expertise, DiCecca has assumed day-to-day leadership of the company, focused on growth and expansion. He will also continue to serve as President of Validation Institute, a World Congress affiliate.  

DiCecca brings an extensive amount of conference experience to World Congress.  Most recently, he led Wellesley Information Services (WIS) for 18 years, serving as CEO for 11 years and President and COO prior to that. Under DiCecca's leadership, WIS grew exponentially, expanding its portfolio to more than 100 domestic and international events generating over $50M in revenues. As a visionary, he also realized new business opportunities and developed new products to connect the world's largest technology companies to Global 1000 businesses.

"We are fortunate to have Benny DiCecca to lead World Congress," said Chairman, Vidar Jorgensen. "His expertise in sales, business strategy, and leadership, combined with his strong conference background, make him ideal to create a positive growth trajectory for World Congress.  

"I am honored to join World Congress as CEO and to be a part of a company focused in transformative industries," said DiCecca. "I look forward to working with the team to build upon the company's 20 years of rich history, particularly its flagship event, the World Health Care Congress, and its HR and employer-focused events. As we move the business forward, we will work to identify and deliver new experiences and opportunities for our customers and partners." 

About World Congress:

World Congress is an innovative, employer-focused company. At our national conferences, leading experts and like-minded professionals gather to share in-depth information and the latest innovations, creating memorable events that generate game-changing opportunities. For more than 20 years, World Congress has been a leader in producing and delivering exceptional conference experiences for senior-level executives from health care, life sciences, employer/wellness, and legal organizations. World Congress events connect the greatest minds in their respective industries to disrupt the status quo and make an impact on their industry, company, and career. For a list of upcoming events, visit www.worldcongress.com/events/

Press Contact:
Sean Edwards
Director, Marketing Operations
World Congress
781-939-2618
[email protected]   

SOURCE World Congress


These press releases may also interest you

at 20:40
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

at 19:40
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

at 19:00
David J. Dykeman, co-chair of the Life Sciences & Medical...

at 18:30
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...

at 17:21
Chemistree Technology Inc. (US OTC: CHMJF) (the "Company" or "Chemistree"), is pleased to announce that the adjourned extraordinary meeting of the holders of the 10% senior unsecured convertible debentures of the Company (the "Debentures") was...



News published on and distributed by: